Drug name - Fotivda
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6821987 | AVEO PHARMS | Quinoline derivatives and quinazoline derivatives having azolyl group |
Apr, 2023
(6 months from now) | |
| US7166722 | AVEO PHARMS | N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n′-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
Nov, 2023
(1 year, 1 month from now) | |
| CN1543459A | AVEO PHARMS | A Group Of Quinoline Derivatives And Quinazoline Derivatives |
Apr, 2022
(5 months ago) | |
| CN1273466C | AVEO PHARMS | A Group Of Quinoline Derivatives And Quinazoline Derivatives |
Apr, 2022
(5 months ago) | |
| IN200301649P1 | AVEO PHARMS | Quinoline And Quinazoline Compounds |
Apr, 2022
(5 months ago) | |
| IN217759B | AVEO PHARMS | Quinoline And Quinazoline Compounds |
Apr, 2022
(5 months ago) | |
| EP1652847A3 | AVEO PHARMS | Quinoline And Quinazoline Derivatives For The Treatment Of Tumors |
Apr, 2022
(5 months ago) | |
| EP1652847B1 | AVEO PHARMS | Quinoline And Quinazoline Derivatives For The Treatment Of Tumors |
Apr, 2022
(5 months ago) | |
| EP1652847A1 | AVEO PHARMS | Quinoline And Quinazoline Derivatives For The Treatment Of Tumors |
Apr, 2022
(5 months ago) | |
| EP1382604B1 | AVEO PHARMS | Quinoline Derivative Having Azolyl Group And Quinazoline Derivative |
Apr, 2022
(5 months ago) | |
| EP1382604A4 | AVEO PHARMS | Quinoline Derivative Having Azolyl Group And Quinazoline Derivative |
Apr, 2022
(5 months ago) | |
| EP1382604A1 | AVEO PHARMS | Quinoline Derivative Having Azolyl Group And Quinazoline Derivative |
Apr, 2022
(5 months ago) | |
| EP1559715A1 | AVEO PHARMS | N-{2-Chloro-4-[(6,7-Dimethoxy-4-Quinolyl)Oxy]Phenyl}-N'-(5-Methyl-3-Isoxazolyl)Urea Salt In Crystalline Form |
Oct, 2023
(1 year, 16 days from now) | |
| EP1559715A4 | AVEO PHARMS | N-¬2-Chloro-4-(6,7-Dimethoxy-4-Quinolyl)OxyPhenyl-N'-(5-Methyl-3-Isoxazolyl)Urea Salt In Crystalline Form |
Oct, 2023
(1 year, 16 days from now) | |
| EP1559715B1 | AVEO PHARMS | N-{2-Chloro-4-[(6,7-Dimethoxy-4-Quinolyl)Oxy]Phenyl}-N'-(5-Methyl-3-Isoxazolyl)Urea Salt In Crystalline Form |
Oct, 2023
(1 year, 16 days from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.89MG BASE | CAPSULE;ORAL | Prescription |
| EQ 1.34MG BASE | CAPSULE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.